Pictet Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Hold
21,923
﹤0.01% 1739
2026
Q1
$163K Buy
21,923
+4,252
+24% +$44.7K ﹤0.01% 1972
2025
Q4
$208K Hold
17,671
﹤0.01% 1901
2025
Q3
$136K Hold
17,671
﹤0.01% 1949
2025
Q2
$129K Hold
17,671
﹤0.01% 1908
2025
Q1
$168K Buy
17,671
+2,540
+17% +$31.7K ﹤0.01% 1834
2024
Q4
$249K Hold
15,131
﹤0.01% 1743
2024
Q3
$223K Hold
15,131
﹤0.01% 1766
2024
Q2
$210K Hold
15,131
﹤0.01% 1731
2024
Q1
$238K Hold
15,131
﹤0.01% 1670
2023
Q4
$245K Buy
15,131
+1,965
+15% +$32.2K ﹤0.01% 1643
2023
Q3
$162K Buy
+13,166
New +$196K ﹤0.01% 1737

Other funds holding NEO

Pictet Asset Management's NEO Position: Q2 2026 in Review

Pictet Asset Management held its NeoGenomics (NEO) position steady in Q2 2026 at 21,923 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Pictet Asset Management first reported a position in NEO in Q3 2023 and has held it in 12 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Pictet Asset Management held 21,923 shares of NeoGenomics worth $320K as of Q2 2026.
  • Pictet Asset Management left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1739 holding.
  • Pictet Asset Management first reported a position in NeoGenomics in Q3 2023 and has held it in 12 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.